Abstract: The Invention pertains to a hardware device designed for mounting, securing, and retaining cymbals on cymbal stands, boom arms and cymbal holders. The device addresses drawbacks of existing cymbal mounting systems by offering unique features that enhance use across a wide range of cymbal stands and cymbal holders by assisting with mounting and removing cymbals, transporting and storing cymbal stands and equipment, and optimizing sound quality of cymbals during use. Key design features enable users to mount cymbals with one hand without having to remove and reinstall a retaining component, and prevent loss of cymbal felts and sleeves when cymbals are removed from cymbal stands or equipment. The length of the device allows secure attachment to cymbal stands and holders with varying cymbal tilter rod lengths. The device eliminates the need for additional mounting components, streamlines the setup process, reduces time-consuming assembly and disassembly, and prevents loss of ancillary components.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, compositions thereof, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Novel pharmaceutical formulations of a beta-2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Novel combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: Novel pharmaceutical formulations of a beta-2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.

Abstract: A skimmer door assembly for use with a skimmer having an opening therein, having a face plate for matingly engaging the skimmer around the opening of the skimmer. The face plate has an opening therein which communicates with the opening of the skimmer. A raised rib portion extends around a periphery of the opening of the face plate. A cover has a first, planar wall which closes the opening of the face plate. The cover has a groove formed on the planar wall which engages the rib of the face plate for sealing the face plate to prevent water from entering the opening of the face plate.